(Q45810866)

16 December 2017

title

Treatment of posthepatitic cirrhosis by Fuzheng Huayu Tablet for reinforcing qi and resolving stasis (English)

1 reference

16 December 2017

0 references

Xin Deng

1

1 reference

16 December 2017

Jian Liang

2

1 reference

16 December 2017

Zhen-Wei Liu

3

1 reference

16 December 2017

Fa-Sheng Wu

4

1 reference

16 December 2017

Xuan Li

5

1 reference

16 December 2017

publication date

2 April 2013

1 reference

16 December 2017

Chinese Journal of Integrated Traditional and Western Medicine

published in

1 reference

16 December 2017

volume

19

1 reference

16 December 2017

issue

4

1 reference

16 December 2017

page(s)

289-296

1 reference

16 December 2017

Hepatic fibrosis: molecular mechanisms and drug targets

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11655-013-1433-7

Immunologic characterization of posthepatitis cirrhosis caused by HBV and HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-013-1433-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-013-1433-7

Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-013-1433-7

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-013-1433-7

Traditional Chinese herbal medicines for treatment of liver fibrosis and cancer: from laboratory discovery to clinical evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-013-1433-7

Therapeutic effect of traditional Chinese medicine on coagulation disorder and accompanying intractable jaundice in hepatitis B virus-related liver cirrhosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-013-1433-7

Effect of anluohuaxian tablet combined with gamma-IFN on schistosomal liver fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-013-1433-7

Clinical research on navel application of Shehuang Paste combined with Chinese herbal colon dialysis in treatment of refractory cirrhotic ascites complicated with azotemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-013-1433-7

Tracing multiscale mechanisms of drug disposition in normal and diseased livers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-013-1433-7

TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-013-1433-7

Effect of umbilical sticking therapy with qitou xiaogu plaster in treating liver cirrhosis patients with portal hypertension

21 January 2018

1 reference

12 December 2020

Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosis

1 reference

12 December 2020

Thoracic complications of liver cirrhosis: radiologic findings

1 reference

12 December 2020

[A study on health-related quality of life in patients with hepatitis B virus related liver cirrhosis]

1 reference

12 December 2020

[The clinical study on chronic hepatitis B treated by the four-step therapeutics of Traditional Chinese Medicine]

1 reference

12 December 2020

Noninvasive markers to diagnose cirrhosis in patients with HBeAg positive chronic hepatitis: Do new biomarkers improve the accuracy?

1 reference

12 December 2020

Adjuvant hepatic chemotherapy after resection of solitary hepatocellular carcinoma associated with hepatitis B virus cirrhosis.

1 reference

12 December 2020

10.1007/S11655-013-1433-7

Identifiers

DOI

1 reference

16 December 2017

Dimensions Publication ID

1024460384

0 references

1 reference

16 December 2017